Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells

Cancer Research

Volumn 57, Issue 8, 1997, Pages 1475-1480

  Jiang, Suping ^a   Kopras, Elizabeth ^a   McMichael, Mary ^a   Bell Jr , Richard H ^b   Ulrich II, Charles D ^a,c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; RECEPTOR SUBTYPE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; GROWTH STIMULATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; SOUTHERN BLOTTING; TISSUE DISTRIBUTION;

ADENOCARCINOMA; BLOTTING, SOUTHERN; CELL DIVISION; CYCLIC AMP; FEMALE; HUMANS; MALE; NEOPLASM PROTEINS; PANCREAS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0030897658     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Niederhuber, J. E., Brennan, M. F., and Menck. H. R. The National Cancer Data Base on pancreatic cancer. Cancer (Phila.), 76: 1671-1677, 1995.
2. Morohoshi, T., Held, G., and Kloppel, G. Exocrine pancreatic tumors and their histological classification: a study based on 167 autopsy and 97 surgical cases. Histopathology, 7: 645-661, 1983.
3. Hall, P. A., and Lemoine, N. R. Models of pancreatic cancer. In: Cancer Surveys: The Molecular Pathology of Cancer, Vol. 16, pp. 135-155, 1993.
4. Gray, M. A., Greenwell, J. R., and Argent, B. E. Secretin-regulated chloride channel on the apical plasma membrane of pancreatic duct cells. J. Membr. Biol., 105: 131-142, 1988.
5. Hoist, J. J., Fahrenkrug, J., Knuhtsen, S., Jensen, S. L., Poulsen, S. S., and Nielsen, O. V. Vasoactive intestinal peptide (VIP) in the pig pancreas: role of VIPergic nerves in the control of fluid and bicarbonate secretion. Regul. Pept., 8: 245-259, 1984.
6. Pollack, P. F., Wood, J. G., and Solomon, T. E. Effect of secretin on growth of stomach, small intestine, and pancreas of developing rats. Dig. Dis. Sci., 35: 749-758, 1990.
7. Ashton, N., Argent, B. E., and Green, R. Effect of vasoactive intestinal polypeptide, bombesin, and substance P on fluid secretion by isolated rat pancreatic ducts. J. Physiol. (Lond.), 427: 471-482, 1990.
8. Pahl, C., and Novak, I. Effect of vasoactive intestinal peptide, carbachol and other agonists on the membrane voltage of pancreatic duct cells. Pflugers Arch., 424: 315-320, 1993.
9. Couvineau, A., Rouyer-Fessard, C., Darmoul, D., Maoret, J., Carrero, I., Ogier-Denis, E., and Laburthe, M. Human intestinal VIP receptor: cloning and functional expression of two cDNAs encoding proteins with different N-terminal domains. Biochem. Biophys. Res. Commun., 200: 769-776, 1994.
10. Adamou, J. E., Aiyar, N., Van Horn, S., and Elshourbagy, N. A. Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor. Biochem. Biophys. Res. Commun. 209: 385-392, 1996.
11. Lilling, G., Wollman, Y., Goldstein, M. N., Rubinraut, S., Fridkin, M., Brenneman, D. E., and Gozes, I. Inhibition of human neuroblastoma growth by a specific VIP antagonist. J. Mol. Neurosci., 5: 231-239, 1995.
12. Moody, T. W., Zia, F., Draoui, M., Brenneman, D. E., Fridkin, M., Davidson, A., and Gozes, I. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth. Proc. Natl. Acad. Sci. USA, 90: 4345-4349, 1993.
13. Maruno, K., and Said, S. I. Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody. Life Sci., 52: PL267-PL271, 1993.
14. Gamet, L., Murat, J. C., Remaury, A., Remesy, C., Valet, P., Paris, H., and Denis-Pouxviel, C. Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line. J. Cell. Pathol., 150: 501-509, 1992.
15. Jiang, S., Bell, R. H., and Ulrich, C. D. Characterization of a human pancreatic secretin receptor and its expression in human ductal pancreatic adenocarcinomas. Gastroenterology, 108: A978, 1995.
16. Virgolini, I., Raderer, M., Kurtaran, A., Angelberger, P., Banyai, S., Yang, G., Li, S., Banyai, M., Pidlich, J., Niederle, B., Scheithauer, W., and Valent. P. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N. Engl. J. Med., 331: 1116-1121, 1994.
17. Reubi, J. C. In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging. J. Nucl. Med., 36: 1846-1853, 1995.
18. Githens, S. Pancreatic duct cell cultures. Annu. Rev. Physiol., 56: 419-443, 1994.
19. Jiang, S., and Ulrich, C. D. Molecular cloning and functional expression of a human pancreatic secretin receptor. Biochem. Biophys. Res. Commun., 207: 883-890, 1995.
20. Holtmann, M., Hadac, E. M., and Miller, L. J. Critical contributions of the amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors. J. Biol. Chem., 270: 14394-14398, 1995.
21. Fahrenkrug, J. Transmitter role of vasoactive intestinal peptide. Pharmacol. Toxicol., 72: 354-363, 1993.
22. Hollande, E., Fanjul, M., Claret, S., Forgue-Lafitte, M. E. and Bara, J. Effects of VIP on the regulation of mucin secretin in cultured human pancreatic cancer cells (Capan-1). In Vitro Cell. Dev. Biol., 31: 227-233, 1995.
23. Waschek, J. A., Richards, M. L., and Bravo, D. T. Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines. Cancer Lett., 92: 143-149, 1995.
24. Estival, A., Mounielou, P., Trocheris, V., Scemama, J. L., Clemente, F., Hollande, E., and Ribet, A. Presence of VIP receptors in a human pancreatic adenocarcinoma cell line, modulation of the cAMP response during cell proliferation. Biochem. Biophys. Res. Commun., 111: 958-963, 1983.
25. Chen, Y., Chen, Q., Lu, G., Fan, Z., and Zhong, S. The autocrine regulatory effect of vasoactive intestinal peptide on the growth of human pancreatic carcinoma cells. Chinese Med. Sci. J., 9: 215-219, 1994.
26. Usdin, T. B., Bonner, T. I., and Mezey, E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology, 135: 2662-2680, 1994.
27. Bissonnette, B. M., Collen, M. J., Adachi, H., Jensen, R. T., and Gardner, J. D. Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini. Am. J. Physiol., 246: G710-G717, 1984.
28. Cory, A. H., Owen, T. C., Barltrop, J. A., and Cory, J. G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun., 3: 207-212, 1991.
29. CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay Technical Bulletin, Promega Corporation, #TB169, 1994.
30. Bergmann, U., Funatomi, H., Yokoyama, M., Beger, H. G., and Korc, M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res., 55: 2007-2011, 1995.
31. Kopras, E., Jiang, S., Myers, J., and Ulrich, C. D. Secretin inhibits growth and MAP kinase activation in recombinant secretin receptor-bearing pancreatic adenocarcinoma-derived cells in vitro. Gastroenterology, 110: A407, 1996.
32. Waschek, J. A. Vasoactive intestinal peptide: an important trophic factor and developmental regulator. Dev. Neurosci., 17: 1-7, 1995.
33. Sreedharan, S. P., Patel, D. R., Xia, M., Ichikawa, S., and Goetzl, E. J. Human vasoactive intestinal peptide-1 receptors expressed by stable transfectants couple to two distinct signaling pathways. Biochem. Biophys. Res. Commun., 203: 141-148, 1994.
34. Taub, D. D., Lloyd, A. R., Conlon, K., Oppenheim, J. J., and Kevlin, D. J. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J. Immunol., 753: 1762-1768, 1994.
35. Pozo, D., Guerrero, J. M., and Calvo, J. R. Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages. Peptides, 16: 313-318, 1995.
36. Bellan, C., Fabre, C., Secchi, J., Marvaldi, J., Pichon, J., and Luis, J. Modulation of the expression of the VIP receptor by serum factors on the human melanoma cell line IGR39. Exp. Cell Res., 200: 34-40, 1992.